Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis
Enclomiphenecitrate for the treatment of secondary male hypogonadism. ExpertOpin Pharmacother
An analyst who modeled LOE based on the 2022 composition patent expiry was off by four years
This leads to a critical strategic challenge: portfolio value is being increasingly concentrated into a small number of mechanisms resulting in a high degree of competition at the indication level
US$ 20.10
US$ 26.39
US$ 22.17
US$ 29.64
US$ 26.72
US$ 20.05
US$ 27.08
